Skip to main content

Advertisement

Log in

IL-6, IL-8 and IL-10 polymorphisms may impact predisposition of Alzheimer’s disease: a meta-analysis

  • Original article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Gene polymorphisms in interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-10 (IL-10) may affect the predisposition of Alzheimer’s disease (AD), but the results of the so far published studies remain controversial. The authors conducted this meta-analysis to assess relationships between IL-6/IL-8/IL-10 polymorphisms and predisposition of AD by pooling the findings of so far published studies. A comprehensive search of Pubmed, Embase, Web of Science, and CNKI was endorsed by the authors to identify the already published studies. Forty-five studies were found to be eligible for meta-analyses. The pooled meta-analyses results showed that genotypic frequencies of IL-6 − 174 G/C, IL-6 − 572 G/C and IL-10 − 1082 A/G polymorphisms among patients with AD and controls differed significantly. Moreover, genotypic frequencies of IL-6 − 174 G/C, IL-6 − 572 G/C, and IL-8 − 251 A/T polymorphisms among patients with AD and controls in Asians also differed significantly. But no such genotypic frequencies’ differences were observed for IL-10 − 819 C/T and 592 C/A polymorphisms. This meta-analysis suggests that IL-6 − 174 G/C, IL-6 − 572 G/C, and IL-10 − 1082 A/G polymorphisms may affect the predisposition of AD in overall population. Moreover, IL-6 − 174 G/C, IL-6 − 572 G/C, and IL-8 − 251 A/T polymorphisms may affect the predisposition of AD in Asians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Gazzaley A, Small SA (2011) Alzheimer's disease. Network 22:173–185

    Article  Google Scholar 

  2. Winner B, Kohl Z, Gage FH (2011) Neurodegenerative disease and adult neurogenesis. Eur J Neurosci 33:1139–1151

    Article  Google Scholar 

  3. Barnes LL, Bennett DA (2014) Alzheimer's disease in African Americans: risk factors and challenges for the future. Health Aff (Millwood) 33:580–586

    Article  Google Scholar 

  4. Faison WE, Schultz SK, Aerssens J, Alvidrez J, Anand R, Farrer LA, Jarvik L, Manly J, McRae T, Murphy GM Jr, Olin JT, Regier D, Sano M (2007) Mintzer JE (2007) Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future. Int Psychogeriatr 19:539–558

    Article  Google Scholar 

  5. Reitz C, Mayeux R (2014) Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations. Biol Psychiatry 75:534–541

    Article  CAS  Google Scholar 

  6. Bertram L, Tanzi RE (2005) The genetic epidemiology of neurodegenerative disease. J Clin Invest 115:1449–1457

    Article  CAS  Google Scholar 

  7. Ramanan VK, Saykin AJ (2013) Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis 2:145–175

    PubMed  PubMed Central  Google Scholar 

  8. Reitz C (2015) Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities. Expert Rev Mol Diagn 15:339–348

    Article  CAS  Google Scholar 

  9. Newcombe EA, Camats-Perna J, Silva ML, Valmas N, Huat TJ, Medeiros R (2018) Inflammation: the link between comorbidities, genetics, and Alzheimer's disease. J Neuroinflammation 15:276

    Article  Google Scholar 

  10. Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16:358–372

    Article  CAS  Google Scholar 

  11. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21:383–421

    Article  CAS  Google Scholar 

  12. Domingues C, da Cruz E, Silva OAB, Henriques AG (2017) Impact of cytokines and chemokines on Alzheimer's disease neuropathological hallmarks. Curr Alzheimer Res 14:870–882

    Article  CAS  Google Scholar 

  13. Su F, Bai F, Zhang Z (2016) Inflammatory cytokines and Alzheimer's disease: a review from the perspective of genetic polymorphisms. Neurosci Bull 32:469–480

    Article  CAS  Google Scholar 

  14. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269

    Article  Google Scholar 

  15. Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605

    Article  Google Scholar 

  16. Smith AJ, Humphries SE (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 20:43–59

    Article  CAS  Google Scholar 

  17. Trenova AG, Slavov GS, Manova MG, Miteva LD, Stanilova SA (2018) A role of cytokine gene polymorphisms in cognitive functioning. Folia Med (Plovdiv) 60:191–199

    Article  Google Scholar 

  18. Cong L, Kong X, Wang J, Du J, Xu Z, Xu Y, Zhao Q (2018) Association between SORL1 polymorphisms and the risk of Alzheimer's disease. J Integr Neurosci 17:185–192

    Article  Google Scholar 

  19. Chouraki V, Seshadri S (2014) Genetics of Alzheimer's disease. Adv Genet 87:245–294

    Article  CAS  Google Scholar 

  20. Zhang CC, Zhu JX, Wan Y, Tan L, Wang HF, Yu JT, Tan L (2017) Meta-analysis of the association between variants in MAPT and neurodegenerative diseases. Oncotarget 8:44994–45007

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

RY and CH designed this meta-analysis. RY and JD searched literatures. FL and PT analyzed the data. RY and CH wrote the manuscript. All authors approved the final manuscript as submitted.

Corresponding author

Correspondence to Chenling Hu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors, thus ethical approval is not required.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 364 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, R., Duan, J., Luo, F. et al. IL-6, IL-8 and IL-10 polymorphisms may impact predisposition of Alzheimer’s disease: a meta-analysis. Acta Neurol Belg 121, 1505–1512 (2021). https://doi.org/10.1007/s13760-020-01369-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-020-01369-4

Keywords

Navigation